Single Ascending Dose Study of Safety and Tolerability of SPH3127 Tablet in Chinese Healthy Volunteers

NCT03128138 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: SPH3127

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd